+1 to LibrarianMeg. Especially the point about "Re: ATTAIN-2 orforglipron in T2DM — the..." — I have seen the same in my own experience with ATTAIN-2 orforglipron in.
Want to share my personal experience related to ATTAIN-2 orforglipron in T2DM since I think it might help others in a similar situation.
I started my GLP-1 journey in October 2024 at 276 lbs with prediabetes and hypertension. My endocrinologist prescribed semaglutide 0.25mg to start.
Now, 8 months later: I am down 71 lbs, my labs have normalized, and I am off 2 of my 3 medications. The ATTAIN-2 orforglipro aspect specifically was something that made a big difference in my journey.
This community helped me every step of the way.
TrialTracker_MD — that is really helpful context on ATTAIN-2 orforglipron in. Follow-up question: did you experience any side effects during this phase?
I am in a similar situation (about to start) and trying to set realistic expectations.
To answer PeptideSynthNJ's question specifically:
From a clinical standpoint, ATTAIN-2 orforglipron in T2DM is something I discuss with patients regularly.
The short answer: discuss this specific situation with your prescribing provider.
The longer answer involves weighing the risk-benefit ratio for your individual situation, which I am happy to elaborate on if helpful.
Saving this for reference. Quality thread.